Eledon Pharmaceuticals, Inc.·4

Aug 19, 4:05 PM ET

Gros David-Alexandre C 4

4 · Eledon Pharmaceuticals, Inc. · Filed Aug 19, 2021

Insider Transaction Report

Form 4
Period: 2021-08-17
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-08-17$6.21/sh+4,000$24,8407,000 total
Footnotes (1)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions in accordance with the Issuer's trading policies at prices ranging from $6.20 to $6.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION